PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Rabeprazole sodium - Acid suppression (Adults)

PAD Profile : Rabeprazole sodium - Acid suppression (Adults) Important

Keywords :
GORD, gastro-oesophageal reflux disease, indigestion, PPIs, Proton pump inhibitors, gastric ulcer, stomach ulcer, dyspepsia
Brand Names Include :
Pariet
Important Information :
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Formulations :
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
07 September 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed that rabeprazole tablets should be restricted for use in patients that cannot have annimal-derived products.

Crushing is not recommended as stomach acid can destroy the active drug

For people with no swallowing difficulties:

  • 1st Line: Lansoprazole capsules/Omeprazole capsules
  • 2nd line: Pantoprazole tablets (Suitable for patients that cannot have animal-derived products) 
  • 2nd line: Rabeprazole tablets (Suitable for patients that cannot have animal-derived products)
  • 3rd line: Esomeprazole capsules – not for new initiation

For patients who cannot swallow tablets/have swallowing difficulties:

  • 1st Line: lansoprazole orodispersible tablets
  • 2nd line: lansoprazole capsules/omeprazole capsules (opened, and granules dispersed in water/yoghurt/apple puree)
  • 3rd line: esomeprazole granule sachets

For patients with enteral feeding tubes:

  • 1st line: lansoprazole orodispersible tablets
  • 2nd line: lansoprazole capsules
  • 3rd line: esomeprazole granule sachets (do not use if tube is less than 6F)

Associated BNF Codes

01. Gastro-Intestinal System
01.03.05. Proton pump inhibitors
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More